Article Information
History
- May 25, 2021.
Article Versions
- Version 1 (April 27, 2021 - 09:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Paul Naaber1,2,*,
- Liina Tserel3,
- Kadri Kangro4,
- Epp Sepp2,
- Virge Jürjenson1,
- Ainika Adamson1,
- Liis Haljasmägi3,
- Pauliina Rumm3,
- Regina Maruste3,
- Jaanika Kärner3,
- Joachim M. Gerhold4,
- Anu Planken4,5,
- Mart Ustav4,
- Kai Kisand3 and
- Pärt Peterson3
- 1SYNLAB Estonia, Tallinn, Estonia
- 2Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
- 3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
- 4Icosagen Cell Factory, Õssu, Kambja, Estonia
- 5Department of Oncology, North-Estonian Medical Centre, Tallinn, Estonia
- ↵*Correspondence
: Paul Naaber, paul.naaber{at}synlab.ee Veerenni 53a, 10138 Tallinn Estonia
Posted May 25, 2021.
